City of Hope® is an independent research and treatment center for cancer, diabetes and other life-threatening diseases. City of Hope offers unparalleled leukemia, lymphoma, multiple myeloma and benign hematology treatment options and exceptional care from experts in all subtypes of the disease with expertise in treating difficult to treat groups, including older patients and those with other chronic conditions. City of Hope’s Hematologic Malignancies Research Institute in Duarte, California, pioneers innovations in hematologic malignancies, stem cell transplants and immune effector cell therapies into early stage clinical trials, ultimately translating them into breakthrough treatments. City of Hope exports the innovation and expertise across our coast-to-coast clinical care network which includes locations in Arizona, California, Georgia and Illinois.
Having performed nearly 19,000 bone marrow and stem cell transplants to-date with unparalleled survivor rates, our expertise includes both autologous and allogeneic stem cell transplants. City of Hope is a leader in cellular immunotherapies, including chimeric antigen receptor (CAR) T cell therapy. We are one of the few institutions in the nation that innovates CAR T cell technology through our own research and clinical trials for hematologic cancers and solid tumors. With more than 900 clinical trials offered annually at City of Hope, patients have access to the newest drugs and treatments before they are widely available.